OR HB2387

Oregon Health Authority must keep confidential information obtained during investigations of psilocybin training programs, licensees, and permit applicants, with limited exceptions for disclosure to law enforcement and regulatory agencies (excluding information about reproductive or gender-affirming health care).

Licensed health care providers (physicians, nurses, psychologists, social workers, counselors, naturopathic physicians, pharmacists) who also hold psilocybin facilitator licenses may conduct preparation and integration sessions alongside their health care services, and may discuss psilocybin services as a treatment option without facing disciplinary action.

The Oregon Psilocybin Advisory Board is restructured from 14-16 members to 9 members appointed by the Governor, including a service center operator, facilitator, tribal representative, mycology expert, harm reduction specialist, behavioral health experts, and two public members.

Psilocybin service center operators must collect and report expanded client demographic data (including veteran status) and track adverse reactions, with information submitted quarterly to OHA and shared with Oregon Health and Science University for outcomes evaluation.

Product labeling requirements now explicitly include psilocin content disclosure, and permits may be denied or revoked for applicants lacking approved criminal records checks under ORS 181A.195; most provisions become operative January 1, 2026.